Aftabul Haque
Principal Biomarker Strategy Leader, Neurology Servier
Seminars
Wednesday 2nd December 2026
Digital Biomarkers: Shaping the Future of Rare Diseases
1:30 pm
- Discuss the strategic value and transformative impact of digital biomarkers in rare disease development
- Tackle the key challenges and mitigations to deployment and validation of digital endpoints in CNS studies
- Enable adoption through fit‑for‑purpose evidence strategies
